Last edition
News about "Antibody-Drug Conjugate "
Innovent Signs Exclusive Global License Deal with Roche for Novel DLL3 Antibody Drug Conjugate
IBI3009 targets DLL3, an antigen with low expression in normal tissues but significantly overexpressed in certain cancers, particularly small-cell lung cancer and other neuroendocrine tumors.
Antibody Drug Conjugate | 02/01/2025 | By Aishwarya
Samsung Biologics Announces Manufacturing Deal with European Pharmaceutical Company
Samsung Biologics is set to add antibody-drug conjugate (ADC) services to its portfolio, with a dedicated facility to be completed by the end of this year.
Antibody-drug Conjugate | 20/11/2024 | By Aishwarya
Chime Biologics and Waterstone to Advance ADC Development and Manufacturing
Through this collaboration, Chime Biologics and Waterstone will offer a comprehensive solution to the ADC developers for IND-enabling and clinical studies.
Antibody-Drug Conjugate | 13/11/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy